FDA Inspection 1311622 — Dr. Arumugam Velappan
The FDA completed an inspection of Dr. Arumugam Velappan on Mar 20, 2026 in Tirunelveli. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Mar 20, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Tirunelveli (India)
Additional details
Clinical BA/BE